HBV整合促进肝细胞癌局部与远端致癌驱动改变
该研究对法国177例主要为欧非裔患者的肿瘤及非肿瘤肝组织行病毒捕获,刻画HBV整合特征。发现复制型HBV DNA多见于非肿瘤组织且与非克隆整合数多相关;克隆性整合通过增强子插入或染色体重排导致TERT、TP53、MYC等驱动基因改变,高整合数患者更年轻且预后差。
要点
- 复制型HBV DNA在非肿瘤肝组织更常见,与非克隆整合数增多相关。
- 克隆性HBV整合可经增强子插入或染色体重排改变TERT、TP53、MYC等驱动基因。
- 高整合数的HCC患者更年轻且预后较差。
核心结论
- HBV整合在肝细胞癌中通过局部增强子插入和远端染色体重排促进致癌驱动改变,具有直接临床意义。
研究设计与样本
- 研究建立病毒捕获流程,对法国177例主要为欧非裔患者的肿瘤与非肿瘤肝组织进行HBV整合分析。
- 每个整合事件的克隆性依据整合序列的定位、方向和内容判定。
- 对3例选定肿瘤使用长读长测序或Bionano全基因组图谱重建复杂整合。
主要发现
- 复制型HBV DNA在非肿瘤组织中更频繁检出,并与更多非克隆整合相关。
- HCC中克隆性HBV整合的选择与两种致癌机制相关:病毒增强子整合至癌症驱动基因附近可致原癌基因强过表达。
- HBV整合位点常见染色体重排,导致TERT、TP53、MYC等癌症驱动基因的远距离改变。
- 高整合数的HCC患者更年轻且预后较差。
临床怎么用
- HBV整合特征可用于识别高整合数、年轻且预后差的HCC患者,提示需加强随访。
- HBV整合通过增强子插入和染色体重排影响TERT、TP53、MYC,可作为潜在致癌机制关注点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Infection by HBV is the main risk factor for hepatocellular carcinoma (HCC) worldwide. HBV directly drives carcinogenesis through integrations in the human genome. This study aimed to precisely characterise HBV integrations, in relation with viral and host genomics and clinical features. DESIGN: A novel pipeline was set up to perform viral capture on tumours and non-tumour liver tissues from a French cohort of 177 patients mainly of European and African origins. Clonality of each integration event was determined with the localisation, orientation and content of the integrated sequence. In three selected tumours, complex integrations were reconstructed using long-read sequencing or Bionano whole genome mapping. RESULTS: Replicating HBV DNA was more frequently detected in non-tumour tissues and associated with a higher number of non-clonal integrations. In HCC, clonal selection of HBV integrations was related to two different mechanisms involved in carcinogenesis. First, integration of viral enhancer nearby a cancer-driver gene may lead to a strong overexpression of oncogenes. Second, we identified frequent chromosome rearrangements at HBV integration sites leading to cancer-driver genes (TERT, TP53, MYC) alterations at distance. Moreover, HBV integrations have direct clinical implications as HCC with a high number of insertions develop in young patients and have a poor prognosis. CONCLUSION: Deep characterisation of HBV integrations in liver tissues highlights new HBV-associated driver mechanisms involved in hepatocarcinogenesis. HBV integrations have multiple direct oncogenic consequences that remain an important challenge for the follow-up of HBV-infected patients.
引用
- Péneau C, Imbeaud S, La Bella T, et al. Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocellular carcinoma. Gut. 2021. PMID: 33563643. doi:10.1136/gutjnl-2020-323153
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。